Drug Type Small molecule drug |
Synonyms asperlicin derivatives(Pfizer), CI-1015, PD-135308 |
Target |
Mechanism CCK receptor antagonists(Cholecystokinin receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC29H39N3O4 |
InChIKeyYKZVFJYBIIABAI-VZHOGKRISA-N |
CAS Registry156672-01-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Discovery | US | - | |
Pain | Discovery | US | - |